
CTRU Complex Interventions
711 posts

CTRU Complex Interventions
@ComplexCTRU
This is the official Twitter account for the Complex Interventions Division within @leedsCTRU, led by Prof @Amanda_Horler



@amanda_horler is a marvellous machine of a human! What a gargantuan effort presenting so much about the exciting proposed LEAP #platform #trial at #uksf23. With co-lead @audreybowenprof (also a marvellous machine), I'm honored to be a co-app and hope it gets funded! 🤞 #rehab

Our very own @JenAirlie and @Drjessjohansson doing a great job manning our poster detailing our reflections on conducting a large, pragmatic multicentre RCT in NHS stroke services at #UKSF23 @AUASResearch @ComplexCTRU




@ComplexCTRU team have arrived at #UKSF23 🥳 Join us tomorrow at our Fringe session at 3.40pm in Hall 7 to learn more about delivering platform trials for stroke survivors through collaboration

Delighted to see the @AtlantisTrial is published in this week’s issue of @TheLancet thelancet.com/journals/lance… In it, we report the effectiveness of amitriptyline as second-line treatment for #IBS in primary care @amanda_horler @HazelEveritt @Dr_SarahA @riddmj @Robbie_Foy

Good to see @AtlantisTrial published in @TheLancet last week in the roundup of this weeks important articles in @bmj_latest. Thanks to collaborators incl. @amanda_horler @HazelEveritt @riddmj @Dr_SarahA @Robbie_Foy

🚨 #UKSF23 Programme OFFICIAL!! 🚨 We are delighted to announce that the #UKSF23 programme is now available online. There are still one or two sessions that are currently TBC but we hope to finalise those shortly! For a full breakdown, please visit stroke.org.uk/professionals/…



New online @TheLancet - Amitriptyline at Low-Dose and Titrated for #IBS as Second-Line Treatment in primary care (ATLANTIS): a randomised, double-blind, placebo-controlled, phase 3 trial Catch the #UEGWeek presentation this pm by @alex_ford12399 thelancet.com/journals/lance…

ATLANTIS trial: titrated low-dose #amitriptyline was superior to placebo as a second-line treatment for #IBS across multiple outcomes, and was safe and well tolerated bit.ly/3tByP66 #visualabstract #dataviz #gastrotwi #Gastroenterology @amanda_horler



New online @TheLancet - Amitriptyline at Low-Dose and Titrated for #IBS as Second-Line Treatment in primary care (ATLANTIS): a randomised, double-blind, placebo-controlled, phase 3 trial Catch the #UEGWeek presentation this pm by @alex_ford12399 thelancet.com/journals/lance…







New preprint 📝❗️ See our new protocol of our process evaluation assessing: 1️⃣Acceptability 2️⃣Fidelity 3️⃣Trial experience in a pilot fractional factorial trial with 4 intervention components supporting medication adherence in women with breast cancer openresearch.nihr.ac.uk/articles/3-3/v1
